For olfactory neuroblastoma (ONB), the combination of surgical tumor resection and radiation therapy (RT) has been considered the “gold standard” in treatment protocols intended to cure.
Objective
To summarize evidence on the treatment of ONB using surgery alone.
Methods
A retrospective institutional case series, a systematic review of the literature, and an individual patient data (IPD) meta-analysis on only surgically treated ONB patients.
Results
At our institution, a total of 10 patients were treated through surgery alone and remained alive and free of disease at last follow-up. The IPD meta-analysis on 128 patients revealed a disease-free survival (DFS) and overall survival (OS) of 67.7% and 75.4% at 5 years and 57.1% and 71.9% at 10 years, respectively. Univariate analysis showed that Kadish stage C/D and Hyams grading III//IV significantly affected OS (P = 0.000 and P = 0.000) and DFS (P = 0.000 and P = 0.002). For low-risk patients, the DFS was 80.6% at 5 years and 67.8% at 10 years, respectively.
Conclusions
Surgery alone is an equivalent alternative to combined treatment in carefully selected low-risk ONB patients with better outcome measures than previously reported.
BroichGPagliariAOttavianiF.Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;
17(4A):2683–2706.
2.
BradleyPJJonesNSRobertsonI.Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolaryngol Head Neck Surg. 2003;
11(2):112–118.
3.
DiazEMJohniganRHPeroC, et al.
Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005;
27(2):138–149.
4.
DulguerovPAllalASCalcaterraTC.Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001;
2(11):683–690.
5.
LundVJHowardDWeiW, et al.
Olfactory neuroblastoma: past, present, and future?Laryngoscope. 2003;
113(3):502–507.
6.
ChaoKSKaplanCSimpsonJR, et al.
Esthesioneuroblastoma: the impact of treatment modality. Head Neck. 2001;
23(9):749–757.
7.
DemirozCGutfeldOAboziadaM, et al.
Esthesioneuroblastoma: is there a need for elective neck treatment?Int J Radiat Oncol Biol Phys. 2011;
81(4):e255–e261.
8.
ArgirisADutraJTsekeP, et al.
Esthesioneuroblastoma: the northwestern university experience. Laryngoscope. 2003;
113:155–160.
9.
BacharGGoldsteinDPShahM, et al.
Esthesioneuroblastoma: the princess margaret hospital experience. Head Neck. 2008;
30(12):1607–1614.
10.
CastelnuovoPBignamiMDeluG, et al.
Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience. Head Neck. 2007;
29(9):845–850.
11.
de GaboryLVerillaudBRumeauC, et al.
Multicenter assessment of exclusive endoscopic endonasal approach for the treatment of 53 olfactory neuroblastomas. Head Neck. 2018;
40(5):1000–1007.
12.
TajudeenBAArshiASuhJD, et al.Esthesioneuroblastoma: an update on the UCLA experience. J Neurol Surg Part B Skull Base. 2002;
76(2013):43–49.
13.
RimmerJLundVJBealeT, et al.
Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope. 2014;
124(7):1542–1549.
14.
MoritaAEbersoldMJOlsenKD, et al.
Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;
32(5):706–714; discussion 714–705.
15.
BillerHFLawsonWSachdevVP, et al.
Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope. 1990;
100(11):1199–1201.
16.
ZafereoMEFakhriSPraysonR, et al.
Esthesioneuroblastoma: 25-year experience at a single institution. Otolaryngol Head Neck Surg. 2008;
138(4):452–458.
17.
NicolaiPCastelnuovoPLombardiD, et al.
Role of endoscopic surgery in the management of selected malignant epithelial neoplasms of the naso-ethmoidal complex. Head Neck. 2007;
29(12):1075–1082.
EdgeSBComptonCC.The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;
17(6):1471–1474.
20.
MoherDLiberatiATetzlaffJ, PRISMA Groupet al.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;
8(5):336–341.
21.
KadishSGoodmanMWangCC.Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer. 1976;
37(3):1571–1576.
22.
DulguerovPCalcaterraT.Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope. 1992;
102(8):843–849.
23.
HarveyRJNalavenkataSSacksR, et al.
Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma. Head Neck. 2017;
39(12):2425–2432.
24.
AustinJRCebrunHKershisnikMM, et al.
Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the M.D. Anderson Cancer Center. Skull Base Surg. 1996;
6(1):1–8.
25.
BäckLOinasMPietarinen-RunttiP, et al.
The developing management of esthesioneuroblastoma: a single institution experience. Eur Arch Otorhinolaryngol. 2012;
269(1):213–221.
26.
ConstantinidisJSteinhartHKochM, et al.
Olfactory neuroblastoma: the university of Erlangen-Nuremberg experience 1975–2000. Otolaryngol Head Neck Surg. 2004;
130(5):567–574.
27.
De BonnecazeGChaputBAl HawatA, et al.
Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma. Acta Otolaryngol. 2014;
134(12): 1259–1264.
28.
de GaboryLAbdulkhaleqHMDarrouzetV, et al.
Long-term results of 28 esthesioneuroblastomas managed over 35 years. Head Neck. 2011;
33(1):82–86.
29.
DiasFLSáGMLimaRA, et al.
Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg. 2003;
129(11):1186–1192.
30.
EdenBVDeboRFLarnerJM, et al.
Long-term outcome and patterns of failure–the university of Virginia experience. Cancer. 1994;
73(10):2556–2562.
31.
EichHTStaarSMickeO, et al.
Radiotherapy of esthesioneuroblastoma. Int J Radiat Oncol Biol Phys. 2001;
49(1):155–160.
32.
FengLFangJZhangL, et al.
Endoscopic endonasal resection of esthesioneuroblastoma: a single center experience of 24 patients. Clin Neurol Neurosurg. 2015;
138:94–98.
33.
FolbeAHerzallahIDuvvuriU, et al.
Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study. Am J Rhinol Allergy. 2009;
23(1):91–94.
34.
GalliaGLAsemotaAOBlitzAM, et al.Endonasal endoscopic resection of olfactory neuroblastoma: an 11-year experience. J Neurosurg. 2018;
131(1): 238–244.
35.
GramSBGrønhøjCMannH, et al.
Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark. Apmis. 2018;
126(8):663–666.
36.
HerrMWSethiRKMeierJC, et al.Esthesioneuroblastoma: an update on the Massachusetts eye and ear infirmary and Massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. J Neurol Surg Part B Skull Base. 2014;
75:58–64.
37.
HollenTRMorrisCGKirwanJM, et al.
Esthesioneuroblastoma of the nasal cavity. Am J Clin Oncol. 2015;
38(3):311–314.
38.
HwangCSSeoYWParkSC, et al.
Role of surgical treatment for esthesioneuroblastomas: 31-year experience at a single institution. J Craniomaxillofac Surg. 2017;
45(1):120–126.
39.
JiangGYLiFCChenWK, et al.
Therapy and prognosis of intracranial invasive olfactory neuroblastoma. Otolaryngol Head Neck Surg. 2011;
145(6):951–955.
40.
KamalEEl-FattahAMAEmamH, et al.
Esthesioneuroblastoma: Mansoura University hospitals’ experience with multimodality therapy in 10 years. Egypt J Ear Nose Throat Allied. 2013;
14(1):17–22.
41.
KlironomosGGonenLAuK, et al.
Endoscopic management of esthesioneuroblastoma: our experience and review of the literature. J Clin Neurosci. 2018;
58:117–123.
42.
KochMConstantinidisJDimmlerA, et al.
Long-term experiences in the therapy of esthesioneuroblastoma. Laryngorhinootologie. 2006;
85(10):723–730.
43.
KokaVNJulieronMBourhisJ, et al.
Aesthesioneuroblastoma. J Laryngol Otol. 1998;
112(7):628–633.
44.
KonigMOsnesTJebsenP, et al.
Olfactory neuroblastoma: a single-center experience. Neurosurg Rev. 2018;
41(1):323–331.
45.
KumarRGhoshalSKhoslaD, et al.
Survival and failure outcomes in locally advanced esthesioneuroblastoma: a single centre experience of 15 patients. Eur Arch Otorhinolaryngol. 2013;
270(6):1897–1901.
46.
LevinePAGallagherRCantrellRW.Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope. 1999;
109(10):1539–1543.
47.
LiRTianSZhuY, et al.
Management of orbital invasion in esthesioneuroblastoma: 14 years’ experience. Radiat Oncol. 2019;
14(1):107.
48.
LoyAHReibelJFReadPW, et al.
Esthesioneuroblastoma: continued follow-up of a single institution's experience. Arch Otolaryngol Head Neck Surg. 2006;
132(2):134–138.
49.
MaloufGGCasiraghiODeutschE, et al.
Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome. Eur J Cancer. 2013;
49(6):1324–1334.
50.
MarinelliJPJanusJRVan GompelJJ, et al.Dural invasion predicts neck metastases in esthesioneuroblastoma. Journal of Neurological Surgery, Part B: Skull Base. 2018;
79: A028.
51.
McLeanJNNunleySRKlassC, et al.
Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg. 2007;
136(6):998–1002.
52.
MichelJFakhryNSantiniL, et al.
Nasal and paranasal esthesioneuroblastomas: clinical outcomes. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;
129(5):238–243.
53.
MillerKCMarinelliJPVan GompelJJ, et al.
Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck. 2019;
41(5): 1335–1341.
54.
MonroeATHinermanRWAmdurRJ, et al.
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck. 2003;
25(7):529–534.
55.
MunozFTresserrasPMontserratJR, et al.
A retrospective study about 11 cases of esthesioneuroblastomas treated in hospital santa creu i sant pau between 2000 and 2008 and literature review. Neurocirugia (Asturias, Spain). 2011;
22(5):401–417; discussion 417–408.
56.
MuscatelloLDallanISecciaV, et al.
Endoscopic endonasal craniotomy in the management of selected ethmoidal malignancies: the university of pisa experience. J Craniomaxillofac Surg. 2011;
39(8):619–623.
57.
NakamuraNZendaSTaharaM, et al.
Proton beam therapy for olfactory neuroblastoma. Radiother Oncol. 2017;
122(3):368–372.
58.
NakaoKWatanabeKFujishiroY, et al.
Olfactory neuroblastoma: long-term clinical outcome at a single institute between 1979 and 2003. Acta Oto-Laryngol Suppl. 2007;
127(sup559):113–117.
59.
NicholsACChanAWCurryWT, et al.
Esthesioneuroblastoma: the Massachusetts eye and ear infirmary and Massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy. Skull Base. 2008;
18(5):327–337.
60.
NohOKLeeS-wYoonSM, et al.
Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach?Int J Radiat Oncol Biol Phys. 2011;
79(2):443–449.
61.
PalejwalaSKSharmaSLeCH, et al.
Complications of advanced Kadish stage esthesioneuroblastoma: single institution experience and literature review. Cureus. 2017;
9(5):e1245.
62.
SakataKAokiYKarasawaK, et al.
Esthesioneuroblastoma. A report of seven cases. Acta Oncol. 1993;
32(4):399–402.
63.
SchmidtCPotterNPorcedduS, et al.
Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance. J Laryngol Otol. 2017;
131(S2):S29–S34.
64.
ShahJPFeghaliJ.Esthesioneuroblastoma.CA: A Cancer Journal for Clinicians. 1983;
33:154–159.
65.
SimonJHZhenWMcCullochTM, et al.
Esthesioneuroblastoma: the university of Iowa experience 1978-1998. Laryngoscope. 2001;
111(3):488–493.
66.
SinghSGQureshiSJainL, et al.
Presentation of lesions of nose and paranasal sinuses at a tertiary care center in Central India. Indian J Otolaryngol Head Neck Surg. 2018;
70(2):284–289.
67.
SurianoMDe VincentiisMColliA, et al.
Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy. Otolaryngol Head Neck Surg. 2007;
136(1):104–107.
68.
TsangRKTsangACLamJW, et al.
Long-term results of endoscopic-assisted cranionasal resection for olfactory neuroblastoma—single centre experience of fourteen patients. Clin Otolaryngol. 2015;
40(3):274–277.
69.
TuralDYildizOSelcukbiricikF, et al.
Olfactory neuroblastomas: an experience of 24 years. ISRN Oncol. 2011;
2011:451086.
70.
UngerFHaselsbergerKWalchC, et al.
Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma). Acta Neurochir (Wien). 2005;
147(6):595–601; discussion 601–592.
71.
WangCCChenYLHsuYSJungSM, et al.
Transcranial resection of olfactory neuroblastoma. Skull Base. 2005;
15(3):163–171; discussion 171.
72.
YuenAPFanYWFungCF, et al.
Endoscopic-assisted cranionasal resection of olfactory neuroblastoma. Head Neck. 2005;
27(6):488–493.
73.
ZhangLNiuKZhuK, et al.
Long-Term prognostic analysis after endoscopic endonasal surgery for olfactory neuroblastoma: a retrospective study of 13 cases. PLoS One . 2016;
11(11):e0166046.
74.
ZhangMZhouLWangDH, et al.
Diagnosis and management of esthesioneuroblastoma. ORL J Otorhinolaryngol Relat Spec. 2010;
72(2):113–118.
75.
ZabelAThilmannCMilker-ZabelS, et al.
The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlentherapie Und Onkologie. 2002;
178(4):187–191.
76.
CastelnuovoPBattagliaPLocatelliD, et al.
Endonasal micro-endoscopic treatment of malignant tumors of the paranasal sinuses and anterior skull base. Operat Tech Otolaryngol Head Neck Surg. 2006;
17(3):152–167.
77.
KaneAJSughrueMERutkowskiMJ, et al.
Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg. 2010;
113(2):340–351.
78.
O’ConnorTAMcLeanPJuillardGJ, et al.
Olfactory neuroblastoma. Cancer. 1989;
63(12):2426–2428.
79.
FooteRLMoritaAEbersoldMJ, et al.
Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1993;
27(4):835–842.
80.
PatelSGSinghBStambukHE, et al.
Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base. 2012;
73(3):208–220.
81.
RestoVAEiseleDWForastiereA, et al.
Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck. 2000;
22(6):550–558.
82.
Van GompelJJGianniniCOlsenKD, et al.
Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival. J Neurol Surg B Skull Base. 2012;
73(5):331–336.
83.
TilsonMPGalliaGLBishopJA.Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol. 2014;
8(1):59–65.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
